Iannone Robert
Jazz Pharmaceuticals PLC · EVP
Iannone Robert is listed in public filings as officer: EVP, Global Head of R&D & CMO. This Iannone Robert insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Jazz Pharmaceuticals PLC (JAZZ), and iTeos Therapeutics, Inc. (ITOS). Investors use Iannone Robert's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $17M88.9k shares | Grant / ExerciseMar 5, 2026 | $1.2M6.2k shares | $188.69 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --95.1k shares | Grant / ExerciseFeb 26, 2026 | Disclosure amount unavailable14.8k shares | -- | -- | |
| $14M80.3k shares | Grant / ExerciseJan 16, 2026 | $708.6K4.1k shares | $171.16 | -- | |
| --84.4k shares | Grant / ExerciseJan 16, 2026 | Disclosure amount unavailable11.7k shares | -- | -- | |
| $12M72.6k shares | SellNov 17, 2025 | $1.2M7.2k shares | $168.26 | -- | |
| $11M79.6k shares | SellMar 10, 2025 | $332.6K2.4k shares | $138.41 | -- | |
| $12M83.6k shares | SellMar 7, 2025 | $764.6K5.5k shares | $138.21 | -- | |
| $11M82k shares | SellMar 7, 2025 | $216.7K1.5k shares | $140.00 | -- | |
| $12M89.1k shares | OtherMar 5, 2025 | $728.0K5.2k shares | $138.95 | -- | |
| --85.5k shares | Grant / ExerciseFeb 27, 2025 | Disclosure amount unavailable17.7k shares | -- | -- | |
| --94.3k shares | Grant / ExerciseFeb 27, 2025 | Disclosure amount unavailable8.9k shares | -- | -- | |
| $8.3M67.8k shares | Grant / ExerciseJan 17, 2025 | $267.4K2.2k shares | $122.62 | -- | |
| --69.9k shares | Grant / ExerciseJan 17, 2025 | Disclosure amount unavailable7.5k shares | -- | -- | |
| $395k24.2k shares | Grant / ExerciseJun 11, 2024 | $394.9K24.2k shares | $16.32 | -- |